2937. Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort.
作者: Katie Wong.;David Pitcher.;Fiona Braddon.;Lewis Downward.;Retha Steenkamp.;Nicholas Annear.;Jonathan Barratt.;Coralie Bingham.;Constantina Chrysochou.;Richard J Coward.;David Game.;Sian Griffin.;Matt Hall.;Sally Johnson.;Durga Kanigicherla.;Fiona Karet Frankl.;David Kavanagh.;Larissa Kerecuk.;Eamonn R Maher.;Shabbir Moochhala.;Jenny Pinney.;John A Sayer.;Roslyn Simms.;Smeeta Sinha.;Shalabh Srivastava.;Frederick W K Tam.;Andrew Neil Turner.;Stephen B Walsh.;Aoife Waters.;Patricia Wilson.;Edwin Wong.;Christopher Mark Taylor.;Dorothea Nitsch.;Moin Saleem.;Detlef Bockenhauer.;Kate Bramham.;Daniel P Gale.; .
来源: Lancet. 2024年403卷10433期1279-1289页
Individuals with rare kidney diseases account for 5-10% of people with chronic kidney disease, but constitute more than 25% of patients receiving kidney replacement therapy. The National Registry of Rare Kidney Diseases (RaDaR) gathers longitudinal data from patients with these conditions, which we used to study disease progression and outcomes of death and kidney failure.
2940. Lung-function trajectories: relevance and implementation in clinical practice.
作者: Erik Melén.;Rosa Faner.;James P Allinson.;Dinh Bui.;Andrew Bush.;Adnan Custovic.;Judith Garcia-Aymerich.;Stefano Guerra.;Robab Breyer-Kohansal.;Jenny Hallberg.;Lies Lahousse.;Fernando D Martinez.;Simon Kebede Merid.;Pippa Powell.;Hilary Pinnock.;Sanja Stanojevic.;Lowie E G W Vanfleteren.;Gang Wang.;Shyamali C Dharmage.;Jadwiga Wedzicha.;Alvar Agusti.; .
来源: Lancet. 2024年403卷10435期1494-1503页
Lung development starts in utero and continues during childhood through to adolescence, reaching its peak in early adulthood. This growth is followed by gradual decline due to physiological lung ageing. Lung-function development can be altered by several host and environmental factors during the life course. As a result, a range of lung-function trajectories exist in the population. Below average trajectories are associated with respiratory, cardiovascular, metabolic, and mental health comorbidities, as well as with premature death. This Review presents progressive research into lung-function trajectories and assists the implementation of this knowledge in clinical practice as an innovative approach to detect poor lung health early, monitor respiratory disease progression, and promote lung health. Specifically, we propose that, similar to paediatric height and weight charts used globally to monitor children's growth, lung-function charts could be used for both children and adults to monitor lung health status across the life course. To achieve this proposal, we introduce our free online Lung Function Tracker tool. Finally, we discuss challenges and opportunities for effective implementation of the trajectory concept at population level and outline an agenda for crucial research needed to support such implementation.
|